Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelinesKetty Peris, Maria Concetta Fargnoli, Claus Garbe et al.|European Journal of Cancer|2019Cited by 589
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trialAlexander Eggermont, B. Guillot, Christian U. Blank et al.|The Lancet Oncology|2021Cited by 389
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022Claus Garbe, Paul Lorigan, Célèste Lebbé et al.|European Journal of Cancer|2022Cited by 320
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022Claus Garbe, Paul Lorigan, Teresa Amaral et al.|European Journal of Cancer|2022Cited by 287
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019Claus Garbe, Alexander M.M. Eggermont, Teresa Amaral et al.|European Journal of Cancer|2019Cited by 214